Products 265312-55-8
CAS 265312-55-8 appears in our catalog under these names: Ryuvidine, Ryuvidine/ 98.6% (existing batch purity), Cdk4 Inhibitor III, Cdk4 Inhibitor III 1PC X 5MG, 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione, 98%, 98%. Offered by: TRC, TargetMol, GLPBio, Biosynth, Sigma-Aldrich. Available pack sizes: 250mg, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 1 mg.
Ryuvidine is a member of the class of benzothiazoles that is 1,3-benzothiazole-4,7-dione substituted by methyl and (4-methylphenyl)amino groups at positions 2 and 5, respectively. It is an inhibitor of CDK4 and SETD8 and exhibits cytotoxicity towards a number of human cancer cell lines. It has a role as an antineoplastic agent and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is an aminotoluene, a member of p-quinones, a member of benzothiazoles and a secondary amino compound.
Source: ChEBI
| Molecular formula | C15H12N2O2S |
|---|---|
| Molecular weight | 284.3 g/mol |
| IUPAC name | 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione |
| InChIKey | HFPLHASLIOXVGS-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(C=C1)NC2=CC(=O)C3=C(C2=O)N=C(S3)C |
Computed by PubChem (NCBI)
Synonyms:
Ryuvidine, Cdk4 Inhibitor III, 2-methyl-5-[(4-methylphenyl)amino]-4,7-dihydro-1,3-benzothiazole-4,7-dione, 2-methyl-5-((4-methylphenyl)amino)-4,7-dihydro-1,3-benzothiazole-4,7-dione, 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione, 2-methyl-5-(p-tolylamino)benzo[d]thiazole-4,7-dione, 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione, Ryuvidine?, 5-(N-(4-Methylphenyl)amino)-2-methyl-4,7-dioxobenzothiazole, 2-Methyl-5-p-tolylamino-benzothiazole-4,7-dione